We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KTOS:NASDAQKratos Defense & Security Solutions, Inc. Analysis

Data as of 2026-06-11 - not real-time

$58.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

KTOS is trading at $58, just above its 20‑day SMA of 57.93 but well below the 50‑day SMA of 62.55 and the 200‑day SMA of 80.29, indicating a bearish medium‑term trend. The RSI sits at 47, suggesting neutral momentum, while the MACD histogram is positive (0.11) with a bullish signal line crossover, hinting at a potential short‑term bounce. Volatility is extremely high at 78.9% over the past 30 days and beta exceeds 2.1, amplifying price swings. Fundamental metrics are stark: a trailing PE of 341× versus an industry average of 30×, forward PE of 54×, and a price‑to‑book of 3.19× despite a modest gross margin of 22.9% and operating margin of only 1.8%. Cash flow is negative, with operating cash flow of -$40.3M and free cash flow of -$106.7M, while debt‑to‑equity is high at 5.44×.
On the upside, the company posted a 22.6% revenue growth year‑over‑year, raised its 2026 revenue guidance, and reported a record backlog, driven by expanding demand for drones, hypersonic systems and the newly scaled Spartan engine production. Analyst sentiment remains positive (median “Buy” recommendation) and the stock enjoys strong institutional interest, yet the valuation gap and cash‑flow constraints keep upside potential limited to the near‑term support zone around $51.66 and the resistance near $66.83.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above 20‑day SMA with bearish longer‑term averages
  • High volatility and beta increasing downside risk
  • Recent Spartan engine expansion providing a modest catalyst

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth (22.6%) and raised 2026 guidance
  • Record backlog and tailwinds in drones, hypersonics, and space contracts
  • Forward PE of 54× still below current trailing PE, suggesting valuation compression

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustained defense spending and strategic market position
  • Persistent cash‑flow deficits and high leverage
  • Valuation remains far above peers, limiting long‑run upside

Key Metrics & Analysis

Financial Health

Revenue Growth22.60%
Profit Margin2.08%
P/E Ratio341.2
ROE1.23%
ROA0.57%
Debt/Equity5.44
P/B Ratio3.2
Op. Cash Flow$-40300000
Free Cash Flow$-106725000
Industry P/E30.3

Technical Analysis

TrendBearish
RSI47.1
Support$51.66
Resistance$66.83
MA 20$57.93
MA 50$62.55
MA 200$80.29
MACDBullish
VolumeStable
Fear & Greed Index85.61

Valuation

Target Price$113.05
Upside/Downside94.91%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.17
Volatility78.86%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.